Latest On NewLink Genetics Corporation (NLNK):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-11-26 20:58 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-08 00:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 13:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 09:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 13:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 01:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 05:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 13:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 17:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 09:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 17:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-26 09:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 05:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 05:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 05:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 05:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 05:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-25 19:38 EST | News | NewLink Genetics EPS beats by $0.06, beats on revenue | N/A | |
| 2020-04-25 19:30 EST | News | NewLink shareholders back Lumos merger | N/A | |
| 2020-04-07 18:24 EST | Insider Trade | CHAD ALLEN JOHNSON has directly acquired 709 shares and currently holds 709 shares. | Buy | |
| 2020-04-07 18:24 EST | Insider Trade | Emmett Cunningham has directly acquired 709 shares and currently holds 709 shares. | Buy | |
| 2020-04-07 18:24 EST | Insider Trade | KEVIN M. LALANDE has directly acquired 709 shares and currently holds 709 shares. | Buy | |
| 2020-04-07 18:24 EST | Insider Trade | Joseph S McCracken has directly acquired 709 shares and currently holds 709 shares. | Buy | |
| 2020-04-07 18:24 EST | Insider Trade | Thomas A. Raffin has directly acquired 709 shares and currently holds 7,889 shares. | Buy | |
| 2020-04-07 18:24 EST | Insider Trade | Lota S. Zoth has directly acquired 709 shares and currently holds 1,820 shares. | Buy | |
| 2020-04-03 21:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 18:26 EST | Insider Trade | Richard J Hawkins has directly acquired 25,000 shares and currently holds 744,575 shares. | Buy | |
| 2020-04-03 18:26 EST | Insider Trade | Eugene P. Kennedy has directly acquired 9,000 shares and currently holds 10,484 shares. | Buy | |
| 2020-04-03 18:26 EST | Insider Trade | Carl W. Langren has directly acquired 9,000 shares and currently holds 11,238 shares. | Buy | |
| 2020-04-03 18:26 EST | Insider Trade | Lori D Lawley has directly acquired 4,500 shares and currently holds 4,842 shares. | Buy | |
| 2020-04-03 18:26 EST | Insider Trade | John C. McKew has directly acquired 13,000 shares and currently holds 13,000 shares. | Buy | |
| 2020-04-03 18:26 EST | Insider Trade | BRADLEY J POWERS has directly acquired 4,500 shares and currently holds 4,555 shares. | Buy | |
| 2020-03-20 05:12 EST | Analyst Rating | The Analyst Target Price has increased from $4 to $36. | Buy | |
| 2020-03-20 05:12 EST | Stock Split | A stock split has occured on Mar 19, 2020 with a split factor of 1:9. | Neutral | |
| 2020-03-02 00:08 EST | Earnings Estimate | An EPS average of -$1.51 is estimated for the 2021 year. | Sell | |
| 2020-03-01 00:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 04:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 21:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 00:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 00:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-07 00:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-01 00:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-29 00:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-28 04:34 EST | Earnings | Earnings have been released on November 6, 2019, with -$0.39 earnings per share. | Sell | |
| 2020-01-28 00:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-25 00:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-16 00:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-06 20:10 EST | Insider Trade | Lota S. Zoth has directly acquired 2,100 shares and currently holds 10,006 shares. | Buy | |
About NewLink Genetics Corporation (NLNK):
NewLink Genetics Corporation, a late clinical-stage immuno-oncology company, focuses on discovering and developing novel immunotherapeutic products for the treatment of patients with cancer. It is developing Indoximod, an indoleamine-2, 3-dioxygenase (IDO) pathway inhibitor that is in clinical development in combination with other cancer therapeutics for patients with diffuse intrinsic pontine glioma, pediatric brain tumors, acute myeloid leukemia, and melanoma. The company also develops NLG207 in combination with paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer; NLG802, a prodrug of indoximod, which has completed Phase I clinical trial; and NLG919, a direct enzymatic inhibitor. The company has collaboration and license agreement with Genentech Inc. for the development and commercialization of NLG919, as well as a research collaboration for the discovery of next generation IDO/TDO inhibitors; and Merck Sharpe & Dohme Corp. to research, develop, and commercialize rVSV G-ZEBOV GP, an Ebola vaccine product candidate. NewLink Genetics Corporation was founded in 1999 and is headquartered in Ames, Iowa.
General
- Name NewLink Genetics Corporation
- Symbol NLNK
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorOther
- IndustryOther
- Full Time Employees 21
- Fiscal Year EndDecember
- IPO Date2011-11-11
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLwww.newlinkgenetics.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 52.15
- Price/Book (Most Recent Quarter) 1.24
- Enterprise Value Revenue 8.94
- Enterprise Value EBITDA 0.08
View More
Financials
- Most Recent Quarter 2019-12-31
- Earnings Per Share -$1.02
- Revenue Per Share $0
- Gross Profit -18969000
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 33.22 million
- EBITDA -45165000
- PEG Ratio -0.23
- Analyst Target Price $36
- Book Value Per Share $2.11
View More
Share Statistics
- % Held by Insiders <1%
- Shares Short 2.31 million
- Shares Short Prior Month 2.23 million
View More
Technicals
- 50 Day Moving Average 8.18
- 200 Day Moving Average 2.75
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
NewLink Genetics Corporation (NLNK) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
NewLink Genetics Corporation (NLNK) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2019-12-31 | 2019-12-31 | $433000 | -$1.98 | -$2.52 | 21.43% |
| 2019-09-30 | 2019-09-30 | $246000 | -$3.51 | -$2.43 | -44.44% |
| 2019-06-30 | 2019-06-30 | $151000 | -$2.43 | -$2.61 | 6.9% |
| 2019-03-31 | 2019-03-31 | $106000 | -$2.43 | -$2.74 | 11.31% |
| 2018-12-31 | 2019-02-28 | $202000 | -$0.28 | -$0.34 | 16.5% |
| 2018-09-30 | 2018-11-01 | $120000 | -$0.20 | -$0.40 | 50.28% |
| 2018-06-30 | 2018-08-01 | $2.25 million | -$0.47 | -$0.60 | 22.37% |
| 2018-03-31 | 2018-05-04 | $9.9 million | -$0.49 | -$0.55 | 10.4% |
| 2017-12-31 | 2018-03-02 | $10.1 million | -$0.37 | -$0.67 | 44.45% |
| 2017-09-30 | 2017-11-02 | $5.48 million | -$0.69 | -$0.77 | 10.53% |
| 2017-06-30 | 2017-07-28 | $10.37 million | -$0.57 | -$0.73 | 21.6% |
| 2017-03-31 | 2017-05-04 | $2.76 million | -$0.72 | -$0.82 | 12.7% |
| 2016-12-31 | 2017-02-28 | $12.7 million | -$0.46 | -$0.62 | 25.26% |
| 2016-09-30 | 2016-11-01 | $15.35 million | -$0.54 | -$0.60 | 10.63% |
| 2016-06-30 | 2016-07-29 | $2.01 million | -$1.12 | -$0.77 | -45.58% |
| 2016-03-31 | 2016-04-29 | $5.31 million | -$0.82 | ||
| 2015-12-31 | 2016-02-29 | $7.65 million | -$0.75 | ||
| 2015-09-30 | 2015-11-03 | $14.21 million | -$0.55 | ||
| 2015-06-30 | 2015-07-31 | $7.45 million | -$0.49 | ||
| 2015-03-31 | 2015-05-05 | $39.2 million | $0.35 | ||
| 2014-12-31 | 2015-02-26 | $169.25 million | $4.05 | ||
| 2014-09-30 | 2014-11-06 | $2.8 million | -$0.20 | ||
| 2014-06-30 | 2014-08-05 | $212000 | -$0.33 | ||
| 2014-03-31 | 2014-05-06 | $334000 | -$0.33 | ||
| 2013-12-31 | 2014-03-12 | $294000 | -$0.31 | ||
| 2013-09-30 | 2013-11-12 | $265000 | -$0.32 | ||
| 2013-06-30 | 2013-08-07 | $232000 | -$0.28 | ||
| 2013-03-31 | 2013-05-06 | $302000 | -$0.33 | ||
| 2012-12-31 | 2013-02-28 | $299000 | -$0.30 | ||
| 2012-09-30 | 2012-10-31 | $327000 | -$0.28 | ||
| 2012-06-30 | 2012-08-14 | $590000 | -$0.31 | ||
| 2012-03-31 | 2012-05-11 | $471000 | -$0.23 | ||
| 2011-12-31 | 2012-03-29 | $301000 | -$0.27 | ||
| 2011-09-30 | 2011-11-30 | $430000 | -$0.19 |
NewLink Genetics Corporation (NLNK) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 |
|---|---|---|---|---|---|
| Research Development | 4.74 million | 7.02 million | 5.24 million | 5.24 million | 5.24 million |
| Income Before Tax | -8.26 million | -14.55 million | -10.13 million | -10.04 million | -10.55 million |
| Selling General Administrative | 4.38 million | 8.28 million | 5.64 million | 5.57 million | 5.43 million |
| Gross Profit | 433000 | 246000 | -5.09 million | -5.1 million | -5.52 million |
| Ebit | -8.69 million | -15.06 million | -10.72 million | -10.66 million | -10.95 million |
| Operating Income | -8.69 million | -15.06 million | -10.72 million | -10.66 million | -10.95 million |
| Income Tax Expense | 12000 | N/A | N/A | N/A | 23000 |
| Total Revenue | 433000 | 246000 | 151000 | 106000 | 202000 |
| Cost of Revenue | N/A | N/A | 5.24 million | 5.2 million | 5.72 million |
| Total Other Income Expense Net | 430000 | 509000 | 590000 | 628000 | 400000 |
| Net Income From Continuing Operations | -8.27 million | -14.55 million | -10.13 million | -10.04 million | -10.57 million |
| Net Income Applicable to Common Shares | -8.27 million | -14.55 million | -10.13 million | -10.04 million | -10.57 million |
Cash Flow:
| Date | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | N/A | 78000 | -848000 | -1.28 million |
| Total Cash Flow from Investing Activities | N/A | N/A | 4000 | 5000 | 6000 |
| Net Borrowings | N/A | N/A | -15000 | -14000 | -29000 |
| Total Cash Flow from Financial Activities | N/A | N/A | 14000 | -46000 | -12000 |
| Change to Operating Activities | N/A | N/A | 433000 | 1.09 million | -630000 |
| Change in Cash | N/A | N/A | -7.81 million | -7.55 million | -1.32 million |
| Total Cash from Operating Activities | N/A | N/A | -7.83 million | -7.51 million | -1.32 million |
| Depreciation | N/A | N/A | 175000 | 192000 | 244000 |
| Other Cash Flow from Investing Activities | N/A | N/A | 4000 | 5000 | 6000 |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | -153000 | 154000 | 241000 |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | N/A | N/A | 1.78 million | 1.94 million | 3.62 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | 7000 |
Balance Sheet:
| Date | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 |
|---|---|---|---|---|---|
| Total Liabailities | 17.91 million | 20.26 million | 22.12 million | 22.25 million | 15.8 million |
| Total Stockholder Equity | 78.88 million | 86.4 million | 98.69 million | 107.02 million | 115.14 million |
| Other Current Liabilities | 11000 | N/A | 836000 | 1.09 million | 741000 |
| Total Assets | 96.79 million | 106.65 million | 120.81 million | 129.27 million | 130.94 million |
| Common Stock | 374000 | 373000 | 373000 | 373000 | 373000 |
| Other Current Assets | N/A | N/A | 4.02 million | 4.45 million | 5.54 million |
| Retained Earnings | -334 million | -325.73 million | -311.18 million | -301.05 million | -291.01 million |
| Other Liabilities | 6 million | 6 million | 6 million | 6 million | 6.91 million |
| Other Assets | N/A | 69000 | 140000 | 140000 | 140000 |
| Cash | 90.55 million | 98.53 million | 105.37 million | 113.18 million | 120.74 million |
| Total Current Liabilities | 11.83 million | 14.04 million | 8.63 million | 8.87 million | 8.85 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 2.37 million | 3.93 million | 10.47 million | 10.85 million | 3.73 million |
| Total Current Assets | 94.42 million | 102.65 million | 110.2 million | 118.28 million | 127.07 million |
| Long Term Investments | N/A | N/A | 140000 | 140000 | 140000 |
| Net Tangible Assets | 78.88 million | 86.4 million | 98.69 million | 107.02 million | 115.14 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | 11000 | 27000 | 43000 |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 475000 | 145000 | 689000 | 896000 | 555000 |
NewLink Genetics Corporation (NLNK) Chart:
NewLink Genetics Corporation (NLNK) News:
Below you will find a list of latest news for NewLink Genetics Corporation (NLNK) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
NewLink Genetics Corporation (NLNK) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
NewLink Genetics Corporation (NLNK) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2019-05-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1126234/000000000019009176/0000000000-19-009176-index.htm |
| 2019-12-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1126234/000000000019016664/0000000000-19-016664-index.htm |
| 2020-01-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1126234/000000000020000626/0000000000-20-000626-index.htm |
| 2020-02-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1126234/000000000020001018/0000000000-20-001018-index.htm |
| 2020-02-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1126234/000000000020001096/0000000000-20-001096-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000021545719004834/0000215457-19-004834-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000021545719007487/0000215457-19-007487-index.htm |
| 2019-12-13 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000090266419004587/0000902664-19-004587-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000093041319000567/0000930413-19-000567-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000101359420000176/0001013594-20-000176-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000103738919000065/0001037389-19-000065-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000103738920000230/0001037389-20-000230-index.htm |
| 2020-04-01 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1126234/000107261320000151/0001072613-20-000151-index.htm |
| 2019-07-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1126234/000110465919040948/0001104659-19-040948-index.htm |
| 2018-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000140/0001126234-18-000140-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000142/0001126234-18-000142-index.htm |
| 2018-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000145/0001126234-18-000145-index.htm |
| 2018-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000147/0001126234-18-000147-index.htm |
| 2018-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000149/0001126234-18-000149-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000152/0001126234-18-000152-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000153/0001126234-18-000153-index.htm |
| 2019-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000003/0001126234-19-000003-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000008/0001126234-19-000008-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000009/0001126234-19-000009-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000010/0001126234-19-000010-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000011/0001126234-19-000011-index.htm |
| 2019-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000013/0001126234-19-000013-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000016/0001126234-19-000016-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000017/0001126234-19-000017-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000020/0001126234-19-000020-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000021/0001126234-19-000021-index.htm |
| 2019-03-05 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000026/0001126234-19-000026-index.htm |
| 2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000027/0001126234-19-000027-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000033/0001126234-19-000033-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000034/0001126234-19-000034-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000035/0001126234-19-000035-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000036/0001126234-19-000036-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000037/0001126234-19-000037-index.htm |
| 2019-03-25 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000040/0001126234-19-000040-index.htm |
| 2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000042/0001126234-19-000042-index.htm |
| 2019-04-05 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000045/0001126234-19-000045-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000049/0001126234-19-000049-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000051/0001126234-19-000051-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000057/0001126234-19-000057-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000058/0001126234-19-000058-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000059/0001126234-19-000059-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000060/0001126234-19-000060-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000061/0001126234-19-000061-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000063/0001126234-19-000063-index.htm |
| 2019-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000065/0001126234-19-000065-index.htm |
| 2019-06-20 | SC TO-I | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000071/0001126234-19-000071-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000073/0001126234-19-000073-index.htm |
| 2019-07-01 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000077/0001126234-19-000077-index.htm |
| 2019-07-22 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000082/0001126234-19-000082-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000084/0001126234-19-000084-index.htm |
| 2019-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000086/0001126234-19-000086-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/0001126234-19-000099-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000100/0001126234-19-000100-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000101/0001126234-19-000101-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000102/0001126234-19-000102-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000103/0001126234-19-000103-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000104/0001126234-19-000104-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000105/0001126234-19-000105-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000106/0001126234-19-000106-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000107/0001126234-19-000107-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000108/0001126234-19-000108-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000109/0001126234-19-000109-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000110/0001126234-19-000110-index.htm |
| 2019-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000112/0001126234-19-000112-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000115/0001126234-19-000115-index.htm |
| 2019-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000118/0001126234-19-000118-index.htm |
| 2019-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000120/0001126234-19-000120-index.htm |
| 2019-08-29 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000122/0001126234-19-000122-index.htm |
| 2019-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000124/0001126234-19-000124-index.htm |
| 2019-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000130/0001126234-19-000130-index.htm |
| 2019-09-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000131/0001126234-19-000131-index.htm |
| 2019-10-01 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000133/0001126234-19-000133-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000136/0001126234-19-000136-index.htm |
| 2019-11-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000137/0001126234-19-000137-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000142/0001126234-19-000142-index.htm |
| 2019-11-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000144/0001126234-19-000144-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000148/0001126234-19-000148-index.htm |
| 2019-11-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1126234/000112623419000152/0001126234-19-000152-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000005/0001126234-20-000005-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000006/0001126234-20-000006-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000007/0001126234-20-000007-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000009/0001126234-20-000009-index.htm |
| 2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000013/0001126234-20-000013-index.htm |
| 2020-02-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000014/0001126234-20-000014-index.htm |
| 2020-03-03 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/0001126234-20-000018-index.htm |
| 2020-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000022/0001126234-20-000022-index.htm |
| 2020-03-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000030/0001126234-20-000030-index.htm |
| 2020-03-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000031/0001126234-20-000031-index.htm |
| 2020-03-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000032/0001126234-20-000032-index.htm |
| 2020-03-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000033/0001126234-20-000033-index.htm |
| 2020-03-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000035/0001126234-20-000035-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000037/0001126234-20-000037-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000044/0001126234-20-000044-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000045/0001126234-20-000045-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000046/0001126234-20-000046-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000047/0001126234-20-000047-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000048/0001126234-20-000048-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000049/0001126234-20-000049-index.htm |
| 2020-04-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000058/0001126234-20-000058-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000059/0001126234-20-000059-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000060/0001126234-20-000060-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000061/0001126234-20-000061-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000062/0001126234-20-000062-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000063/0001126234-20-000063-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000064/0001126234-20-000064-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000067/0001126234-20-000067-index.htm |
| 2020-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000070/0001126234-20-000070-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000072/0001126234-20-000072-index.htm |
| 2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000074/0001126234-20-000074-index.htm |
| 2020-06-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000076/0001126234-20-000076-index.htm |
| 2019-11-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000114036119020976/0001140361-19-020976-index.htm |
| 2019-11-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000114036119020977/0001140361-19-020977-index.htm |
| 2019-11-20 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000114036119020980/0001140361-19-020980-index.htm |
| 2019-11-20 | PREM14A | Preliminary proxy statements relating to merger or acquisition | https://www.sec.gov/Archives/edgar/data/1126234/000114036119020983/0001140361-19-020983-index.htm |
| 2019-12-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000114036119022561/0001140361-19-022561-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000114036119022996/0001140361-19-022996-index.htm |
| 2019-12-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000114036119022997/0001140361-19-022997-index.htm |
| 2020-01-09 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1126234/000114036120000548/0001140361-20-000548-index.htm |
| 2020-01-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1126234/000114036120000550/0001140361-20-000550-index.htm |
| 2020-01-29 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1126234/000114036120001626/0001140361-20-001626-index.htm |
| 2020-01-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1126234/000114036120001627/0001140361-20-001627-index.htm |
| 2020-02-04 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1126234/000114036120002171/0001140361-20-002171-index.htm |
| 2020-02-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1126234/000114036120002172/0001140361-20-002172-index.htm |
| 2020-02-10 | DEFM14A | Definitive proxy statement relating to merger or acquisition | https://www.sec.gov/Archives/edgar/data/1126234/000114036120002644/0001140361-20-002644-index.htm |
| 2020-02-13 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/1126234/000114036120003160/0001140361-20-003160-index.htm |
| 2020-03-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1126234/000114036120005019/0001140361-20-005019-index.htm |
| 2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000114036120006205/0001140361-20-006205-index.htm |
| 2020-06-01 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1126234/000114036120012764/0001140361-20-012764-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000114420419008084/0001144204-19-008084-index.htm |
| 2020-03-30 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1126234/000119312520091134/0001193125-20-091134-index.htm |
| 2020-03-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1126234/000119380520000380/0001193805-20-000380-index.htm |
| 2019-03-18 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000121465919002152/0001214659-19-002152-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000132544719000011/0001325447-19-000011-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000151211319000002/0001512113-19-000002-index.htm |
| 2020-02-18 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1126234/000151211320000002/0001512113-20-000002-index.htm |
| 2019-07-22 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1126234/999999999519001657/9999999995-19-001657-index.htm |
| 2018-12-17 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1126234/999999999718009561/9999999997-18-009561-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1126234/999999999719001409/9999999997-19-001409-index.htm |
NewLink Genetics Corporation (NLNK) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NewLink Genetics Corporation (NLNK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: < 1%Institutional Ownership: < 1%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-01-02 | Lota S. Zoth | Director | Buy | 2,100.00 | 10,006.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000007/0001126234-20-000007-index.htm | ||
| 2020-04-01 | Eugene P. Kennedy | Chief Medical Officer | Buy | 9,000.00 | 10,484.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000045/0001126234-20-000045-index.htm | ||
| 2020-04-01 | Carl W. Langren | Chief Financial Officer | Buy | 9,000.00 | 11,238.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000046/0001126234-20-000046-index.htm | ||
| 2020-04-01 | John C. McKew | Chief Scientific Officer | Buy | 13,000.00 | 13,000.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000048/0001126234-20-000048-index.htm | ||
| 2020-04-03 | Lota S. Zoth | Director | Buy | 709.00 | 1,820.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000064/0001126234-20-000064-index.htm | ||
| 2018-12-12 | Carl W. Langren | Chief Financial Officer | Buy | 2,564.00 | 0.80 | 2,051.20 | 21,469.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000152/0001126234-18-000152-index.htm |
| 2018-12-12 | Charles J. Jr. Link | Chairman of the Board and CEO | Buy | 2,564.00 | 0.80 | 2,051.20 | 262,406.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623418000153/0001126234-18-000153-index.htm |
| 2020-04-01 | BRADLEY J POWERS | General Counsel | Buy | 4,500.00 | 4,555.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000049/0001126234-20-000049-index.htm | ||
| 2020-04-01 | Lori D Lawley | Principal Accounting Officer | Buy | 4,500.00 | 4,842.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000047/0001126234-20-000047-index.htm | ||
| 2020-04-03 | CHAD ALLEN JOHNSON | Director | Buy | 709.00 | 709.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000059/0001126234-20-000059-index.htm | ||
| 2020-04-03 | Emmett Cunningham | Director | Buy | 709.00 | 709.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000060/0001126234-20-000060-index.htm | ||
| 2020-04-03 | Joseph S McCracken | Director | Buy | 709.00 | 709.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000062/0001126234-20-000062-index.htm | ||
| 2020-04-03 | KEVIN M. LALANDE | Director | Buy | 709.00 | 709.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000061/0001126234-20-000061-index.htm | ||
| 2020-04-01 | Richard J Hawkins | Chief Executive Officer | Buy | 25,000.00 | 744,575.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000044/0001126234-20-000044-index.htm | ||
| 2020-04-03 | Thomas A. Raffin | Director | Buy | 709.00 | 7,889.00 | https://www.sec.gov/Archives/edgar/data/1126234/000112623420000063/0001126234-20-000063-index.htm |